1.Comparative analysis on the 2024 Japanese guidelines for management of lung nodules detected by low-dose CT lung cancer screening and the 2023 Chinese guidelines for low-dose CT lung cancer screening
Jing FENG ; Jianbing YIN ; Lei CUI
Chinese Journal of Oncology 2025;47(8):763-768
Lung cancer is one of the leading causes of cancer-related mortality worldwide. Low-dose CT screening can increase the detection rate of early-stage lung cancer and reduce lung cancer mortality. This article compares and analyzes the latest Japanese and Chinese guidelines for low-dose CT lung cancer screening, exploring the commonalities and differences between the two countries in the construction of lung cancer screening systems and the detailed management of lung nodules. Both guidelines emphasize the importance of age and smoking in selecting screening candidates, but the specific criteria differ. The Japanese guideline targets heavy smokers aged 50-74 years, while its Chinese counterpart targets a broader high-risk population, including individuals with different ages, smoking histories, occupational exposures, and family genetic factors. In terms of equipment and radiation dose requirements, both guidelines consider individualization, but there are differences in specific values and methods. Regarding imaging and post-processing analysis, the Chinese guideline provides more detailed technical specifications, emphasizing the use of various post-processing techniques. In lung nodule management strategies, both guidelines adopt nodule classification, but there are differences in nodule size assessment criteria and follow-up intervention procedures, with the Chinese guideline placing greater emphasis on multidisciplinary team consultations. The Japanese guideline highlights easily overlooked imaging features of lung cancer and non-nodule manifestations, while the Chinese guideline emphasizes the integration of smoking cessation and lung cancer screening. Overall, the guidelines of the two countries share commonalities in many aspects of lung cancer screening but also have their own characteristics, and learning from each other can help improve lung cancer screening systems.
2.A multicenter clinical study on intramedullary vancomycin injection for preventing periprosthetic joint infection in total knee arthroplasty
Te LIU ; Jun FU ; Shiguang LAI ; Zhuo ZHANG ; Chi XU ; Lei GENG ; Yang LUO ; Peng REN ; Xin ZHI ; Quanbo JI ; Heng ZHANG ; Runkai ZHAO ; Haichao REN ; Ye TAO ; Qingyuan ZHENG ; Zeyu FENG ; Jianfeng YANG ; Yiming WANG ; Pengcheng LI ; Shuai LIU ; Wei CHAI ; Xiang LI ; Huiwu LI ; Xiaogang ZHANG ; Baochao JI ; Xianzhe LIU ; Xinzhan MAO ; Jianbing MA ; Xiangxiang SUN ; Jiying CHEN ; Yonggang ZHOU ; Jinliang WANG ; Weijun WANG ; Guoqiang ZHANG ; Ming NI
Chinese Journal of Orthopaedics 2025;45(12):803-811
Objective:To explore the safety and efficacy of intraosseous regional administration (IORA) of vancomycin for preventing infection in primary total knee arthroplasty (TKA).Methods:A total of 124 patients with knee osteoarthritis undergoing TKA between February 2024 and May 2024 at nine hospitals were enrolled. Preoperative infection prophylaxis involved either IORA (0.5 g vancomycin administered via intraosseous regional infusion before incision) or intravenous infusion (1 g vancomycin via peripheral vein). The IORA group included 15 males and 47 females with a median age of 66.5 years (range, 60.0-70.0 years), while the intravenous group included 14 males and 48 females with a median age of 66.0 years (range, 61.8-70.3 years) years. Intraoperative samples were collected including fat and synovium tissues after incision, before prosthesis placement, and after tourniquet release; distal femoral cancellous bone during femoral osteotomy; proximal tibial cancellous bone during tibial osteotomy; proximal intercondylar cancellous bone before prosthesis placement; and peripheral blood from non-infused arms at surgery initiation and after tourniquet release. Vancomycin concentrations were measured using liquid chromatography-tandem mass spectrometry. Vital sign changes were recorded from admission to 5~10 minutes post-IORA (IORA group) or post-incision (intravenous group). Follow-ups were conducted on postoperative day 1 and 3, and at 1 and 3 months, to document complications including IORA-related adverse events, periprosthetic joint infections, surgical site infections, red man syndrome, acute kidney injury, deep vein thrombosis and so on.Results:Vancomycin concentrations in bone, fat, and synovial tissue samples were significantly higher in the IORA group than in the intravenous group ( P<0.05), while vancomycin concentrations in blood samples were significantly lower in the IORA group than in the intravenous group ( P<0.05). Only 7.3%(41/558) of tissue samples in the IORA group had vancomycin concentrations below 2.0 μg/g (the minimum inhibitory concentration of vancomycin against coagulase-negative staphylococcus), compared to 59.3%(331/558) in the intravenous group (χ 2=11.285, P<0.001). In the intravenous group, 16.9%(21/124) of blood samples had vancomycin concentrations exceeding 15.0 mg/L (the threshold associated with a significantly increased risk of nephrotoxicity), while all concentrations in the IORA group were below this threshold, the difference was statistically significant (χ 2=22.943, P<0.001). There were no statistically significant difference ( P>0.05) in vital signs changes before and after vancomycin administration between the two groups. Two patients in the intravenous group experienced incision exudate, while no other related complications occurred in either group. Conclusions:Compared to the traditional intravenous infusion of 1 g vancomycin, intraosseous injection of a low dose (0.5 g) of vancomycin achieves higher local tissue concentrations in the knee joint with a lower incidence of adverse reactions and is safe for infection prophylaxis. Despite guidelines not recommending the routine use of vancomycin for preventing infection after primary TKA, intraosseous injection of 0.5 g vancomycin may be considered intraoperatively for primary TKA in the following scenarios: patients in medical institutions with a high prevalence of methicillin-resistant staphylococcus aureus (MRSA) infections, patients with potential preoperative MRSA colonization, or patients with cephalosporin allergy.
3.Comparative analysis on the 2024 Japanese guidelines for management of lung nodules detected by low-dose CT lung cancer screening and the 2023 Chinese guidelines for low-dose CT lung cancer screening
Jing FENG ; Jianbing YIN ; Lei CUI
Chinese Journal of Oncology 2025;47(8):763-768
Lung cancer is one of the leading causes of cancer-related mortality worldwide. Low-dose CT screening can increase the detection rate of early-stage lung cancer and reduce lung cancer mortality. This article compares and analyzes the latest Japanese and Chinese guidelines for low-dose CT lung cancer screening, exploring the commonalities and differences between the two countries in the construction of lung cancer screening systems and the detailed management of lung nodules. Both guidelines emphasize the importance of age and smoking in selecting screening candidates, but the specific criteria differ. The Japanese guideline targets heavy smokers aged 50-74 years, while its Chinese counterpart targets a broader high-risk population, including individuals with different ages, smoking histories, occupational exposures, and family genetic factors. In terms of equipment and radiation dose requirements, both guidelines consider individualization, but there are differences in specific values and methods. Regarding imaging and post-processing analysis, the Chinese guideline provides more detailed technical specifications, emphasizing the use of various post-processing techniques. In lung nodule management strategies, both guidelines adopt nodule classification, but there are differences in nodule size assessment criteria and follow-up intervention procedures, with the Chinese guideline placing greater emphasis on multidisciplinary team consultations. The Japanese guideline highlights easily overlooked imaging features of lung cancer and non-nodule manifestations, while the Chinese guideline emphasizes the integration of smoking cessation and lung cancer screening. Overall, the guidelines of the two countries share commonalities in many aspects of lung cancer screening but also have their own characteristics, and learning from each other can help improve lung cancer screening systems.
4.A multicenter clinical study on intramedullary vancomycin injection for preventing periprosthetic joint infection in total knee arthroplasty
Te LIU ; Jun FU ; Shiguang LAI ; Zhuo ZHANG ; Chi XU ; Lei GENG ; Yang LUO ; Peng REN ; Xin ZHI ; Quanbo JI ; Heng ZHANG ; Runkai ZHAO ; Haichao REN ; Ye TAO ; Qingyuan ZHENG ; Zeyu FENG ; Jianfeng YANG ; Yiming WANG ; Pengcheng LI ; Shuai LIU ; Wei CHAI ; Xiang LI ; Huiwu LI ; Xiaogang ZHANG ; Baochao JI ; Xianzhe LIU ; Xinzhan MAO ; Jianbing MA ; Xiangxiang SUN ; Jiying CHEN ; Yonggang ZHOU ; Jinliang WANG ; Weijun WANG ; Guoqiang ZHANG ; Ming NI
Chinese Journal of Orthopaedics 2025;45(12):803-811
Objective:To explore the safety and efficacy of intraosseous regional administration (IORA) of vancomycin for preventing infection in primary total knee arthroplasty (TKA).Methods:A total of 124 patients with knee osteoarthritis undergoing TKA between February 2024 and May 2024 at nine hospitals were enrolled. Preoperative infection prophylaxis involved either IORA (0.5 g vancomycin administered via intraosseous regional infusion before incision) or intravenous infusion (1 g vancomycin via peripheral vein). The IORA group included 15 males and 47 females with a median age of 66.5 years (range, 60.0-70.0 years), while the intravenous group included 14 males and 48 females with a median age of 66.0 years (range, 61.8-70.3 years) years. Intraoperative samples were collected including fat and synovium tissues after incision, before prosthesis placement, and after tourniquet release; distal femoral cancellous bone during femoral osteotomy; proximal tibial cancellous bone during tibial osteotomy; proximal intercondylar cancellous bone before prosthesis placement; and peripheral blood from non-infused arms at surgery initiation and after tourniquet release. Vancomycin concentrations were measured using liquid chromatography-tandem mass spectrometry. Vital sign changes were recorded from admission to 5~10 minutes post-IORA (IORA group) or post-incision (intravenous group). Follow-ups were conducted on postoperative day 1 and 3, and at 1 and 3 months, to document complications including IORA-related adverse events, periprosthetic joint infections, surgical site infections, red man syndrome, acute kidney injury, deep vein thrombosis and so on.Results:Vancomycin concentrations in bone, fat, and synovial tissue samples were significantly higher in the IORA group than in the intravenous group ( P<0.05), while vancomycin concentrations in blood samples were significantly lower in the IORA group than in the intravenous group ( P<0.05). Only 7.3%(41/558) of tissue samples in the IORA group had vancomycin concentrations below 2.0 μg/g (the minimum inhibitory concentration of vancomycin against coagulase-negative staphylococcus), compared to 59.3%(331/558) in the intravenous group (χ 2=11.285, P<0.001). In the intravenous group, 16.9%(21/124) of blood samples had vancomycin concentrations exceeding 15.0 mg/L (the threshold associated with a significantly increased risk of nephrotoxicity), while all concentrations in the IORA group were below this threshold, the difference was statistically significant (χ 2=22.943, P<0.001). There were no statistically significant difference ( P>0.05) in vital signs changes before and after vancomycin administration between the two groups. Two patients in the intravenous group experienced incision exudate, while no other related complications occurred in either group. Conclusions:Compared to the traditional intravenous infusion of 1 g vancomycin, intraosseous injection of a low dose (0.5 g) of vancomycin achieves higher local tissue concentrations in the knee joint with a lower incidence of adverse reactions and is safe for infection prophylaxis. Despite guidelines not recommending the routine use of vancomycin for preventing infection after primary TKA, intraosseous injection of 0.5 g vancomycin may be considered intraoperatively for primary TKA in the following scenarios: patients in medical institutions with a high prevalence of methicillin-resistant staphylococcus aureus (MRSA) infections, patients with potential preoperative MRSA colonization, or patients with cephalosporin allergy.
5.Analysis of factors associated with spread through air spaces(STAS) of small adenocarcinomas(≤2 cm) in peripheral stage ⅠA lungs and modeling of nomograms
Jing FENG ; Wei SHAO ; Xiayin CAO ; Jia LIU ; Jialei MING ; Ya’nan ZHANG ; Jianbing YIN ; Jin CHEN ; Honggang KE ; Lei CUI
Chinese Journal of Thoracic and Cardiovascular Surgery 2024;40(3):129-136
Objective:To investigate the relationship between spread through air spaces(STAS) of peripheral stage ⅠA small adenocarcinoma of the lung(≤2 cm) and related factors such as clinical and CT morphological features, and to construct a nomogram model.Methods:Relevant clinical, pathological and imaging data of patients who underwent lung surgery and were diagnosed as peripheral stage ⅠA small lung adenocarcinoma by postoperative pathology in the Affiliated Hospital of Nantong University from 2017 to 2022 were collected, of which cases that met the inclusion criteria from 2017 to 2021 served as the training group, and those that met the inclusion criteria in 2022 served as the validation group. The independent risk factors for the occurrence of STAS in peripheral stage ⅠA lung small adenocarcinoma were investigated by using univariate analysis and multifactorial logistic regression analysis, based on which a nomogram prediction model was constructed, and the subjects were analyzed by using the receiver operating characteristic curve( ROC), correction model, etc. were used to evaluate the model. Results:A total of 430 patients who met the criteria were included, including 351 patients in the training group(109 STAS-positive and 242 STAS-negative) and 79 patients in the validation group(23 STAS-positive and 56 STAS-negative). Univariate analysis showed that the patients in the two groups showed a significant difference in age(>58 years old), gender, smoking history, tumor location(subpleural, non-subpleural), pleural pull, nodule type, nodule maximal diameter, solid component maximal diameter, consolidation tumor ratio(CTR), lobulation sign, burr sign, bronchial truncation sign, vascular sign(includes thickening and distortion of blood vessels in/around the nodes), satellite lesions, and ground-glass band sign were statistically significant( P<0.05). The results of multifactorial logistic regression analysis showed that CTR( OR=4.98, P<0.001), lobulation sign( OR=4.07, P=0.013), burr sign( OR=3.66, P<0.001), and satellite lesions( OR=3.56, P=0.009) were the independent risk factors for the occurrence of STAS. Applying the above factors to construct the nomogram model and validate the model, the results showed that the ROC curve was plotted by the nomogram prediction model, and the area under the ROC curve( AUC) of the training set was 0.840(sensitivity 0.835, specificity 0.734), and the validation set had an AUC value of 0.852(sensitivity 0.786, specificity 0.783), and the training set and validation set calibration curves have good overlap with the ideal curve. Conclusion:CTR, lobular sign, burr sign, and satellite lesions are independent risk factors for STAS, and the nomogram model constructed in this study has good predictive value.
6.Ginkgo biloba extract protects against depression-like behavior in mice through regulating gut microbial bile acid metabolism.
Junchi ZHOU ; Qilin FAN ; Xiaoying CAI ; Youying ZHANG ; Yuanlong HOU ; Shuqi CAO ; Ziguang LI ; Mengzhen FENG ; Qingqing WANG ; Jianbing ZHANG ; Guangji WANG ; Xiao ZHENG ; Haiping HAO
Chinese Journal of Natural Medicines (English Ed.) 2023;21(10):745-758
Depression is a mental disorder with high morbidity, disability and relapse rates. Ginkgo biloba extract (GBE), a traditional Chinese medicine, has a long history of clinical application in the treatment of cerebral and mental disorders, but the key mechanism remains incompletely understood. Here we showed that GEB exerted anti-depressant effect in mice through regulating gut microbial metabolism. GBE protected against unpredictable mild stress (UMS)-induced despair, anxiety-like and social avoidance behavior in mice without sufficient brain distribution. Fecal microbiome transplantation transmitted, while antibiotic cocktail abrogated the protective effect of GBE. Spatiotemporal bacterial profiling and metabolomics assay revealed a potential involvement of Parasutterella excrementihominis and the bile acid metabolite ursodeoxycholic acid (UDCA) in the effect of GBE. UDCA administration induced depression-like behavior in mice. Together, these findings suggest that GBE acts on gut microbiome-modulated bile acid metabolism to alleviate stress-induced depression.
Humans
;
Mice
;
Animals
;
Depression/drug therapy*
;
Gastrointestinal Microbiome
;
Plant Extracts
;
Ginkgo biloba
7.Chinese expert consensus on the technical standard of direct anterior hip arthroplasty for elderly femoral neck fracture (version 2023)
Zhonghua XU ; Lun TAO ; Zaiyang LIU ; Yang LI ; Jie LI ; Jun ZHANG ; Xia ZHANG ; Min WANG ; Changqing LI ; Guangxing CHEN ; Liu YANG ; Dawei ZHANG ; Xiaorui CAO ; Guoqiang ZHANG ; Pingyue LI ; Nirong BAO ; Chuan LI ; Shenghu ZHOU ; Zhengqi CHANG ; Bo WU ; Wenwei QIAN ; Weiguo WANG ; Ming LYU ; Hao TANG ; Hu LI ; Chuan HE ; Yunsu CHEN ; Huiwu LI ; Ning HU ; Mao NIE ; Feng XIE ; Zhidong CAO ; Pengde KANG ; Yan SI ; Chen ZHU ; Weihua XU ; Xianzhe LIU ; Xinzhan MAO ; Jie XIE ; Xiaogang ZHANG ; Boyong XU ; Pei YANG ; Wei WANG ; Xiaofeng LI ; Eryou FENG ; Zhen ZHANG ; Baoyi LIU ; Jianbing MA ; Hui LI ; Yuanchen MA ; Li SUN ; Zhifeng ZHANG ; Shuo GENG ; Guanbao LI ; Yuji WANG ; Erhu LI ; Zongke ZHOU ; Wei HUANG ; Yixin ZHOU ; Li CAO ; Wei CHAI ; Yan XIONG ; Yuan ZHANG
Chinese Journal of Trauma 2023;39(11):961-973
Femoral neck fracture (FNF) in the elderly patients is currently a major health challenge worldwide, with excessive consumption of medical resources, high incidence of complications as well as suboptimal outcome and prognosis. Hip joint arthroplasty (HJA) has been the mainstream treatment for FNF in the elderly, but the conventional surgical approaches and techniques are still confronted with a series of bottlenecks such as dislocation, limp and limb length discrepancy. In recent years, direct anterior approach (DAA) for HJA (DAA-HJA) has been a major new choice in the field of joint replacement, which achieves improved clinical effectiveness of HJA in the treatment of elderly FNF, due to the fact that DAA approach involves the neuromuscular interface and accords with the idea of soft tissue retention and enhanced recovery after surgery. However, there is still a lack of unified understanding of standard technique and procedure of DAA-HJA in the treatment of elderly FNF. Therefore, relevant experts from the Hip Joint Group of Chinese Orthopedics Association of Chinese Medical Association, Youth Arthrology Group of Orthopedic Committee of PLA, Orthopedic Committee of Chongqing Medical Association, Branch of Orthopedic Surgeons of Chongqing Medical Doctor Association and Sport Medicine Committee of Chongqing Medical Association were organized to formulate the " Chinese expert consensus on the technical standard of direct anterior hip arthroplasty for elderly femoral neck fracture ( version 2023)" based on evidence-based medicine. This consensus mainly proposed 13 recommendations covering indications, surgical plans, prosthesis selections, surgical techniques and processes, and postoperative management of DAA-HJA in elderly patients with FNF, aiming to promote standardized, systematic and patient-specific diagnosis and treatment to improve the functional prognosis of the patients.
8.Automatic segmentation of kidney tumor based on cascaded multiscale convolutional neural networks.
Hong JI ; Xusheng QIAN ; Zhiyong ZHOU ; Jianbing ZHU ; Lushuang YE ; Feng WANG ; Yakang DAI
Journal of Biomedical Engineering 2021;38(4):722-731
The background of abdominal computed tomography (CT) images is complex, and kidney tumors have different shapes, sizes and unclear edges. Consequently, the segmentation methods applying to the whole CT images are often unable to effectively segment the kidney tumors. To solve these problems, this paper proposes a multi-scale network based on cascaded 3D U-Net and DeepLabV3+ for kidney tumor segmentation, which uses atrous convolution feature pyramid to adaptively control receptive field. Through the fusion of high-level and low-level features, the segmented edges of large tumors and the segmentation accuracies of small tumors are effectively improved. A total of 210 CT data published by Kits2019 were used for five-fold cross validation, and 30 CT volume data collected from Suzhou Science and Technology Town Hospital were independently tested by trained segmentation models. The results of five-fold cross validation experiments showed that the Dice coefficient, sensitivity and precision were 0.796 2 ± 0.274 1, 0.824 5 ± 0.276 3, and 0.805 1 ± 0.284 0, respectively. On the external test set, the Dice coefficient, sensitivity and precision were 0.817 2 ± 0.110 0, 0.829 6 ± 0.150 7, and 0.831 8 ± 0.116 8, respectively. The results show a great improvement in the segmentation accuracy compared with other semantic segmentation methods.
Humans
;
Kidney Neoplasms/diagnostic imaging*
;
Neural Networks, Computer
;
Specimen Handling
;
Tomography, X-Ray Computed
9.Comparison of different ovarian hyperstimulation protocols efficacy in poor ovarian responders classified by Poseidon criteria
Fei LI ; Aiqin NIU ; Jianbing FENG ; Chenchen WANG ; Xingmei FENG ; Yali ZHANG ; Ying CHEN
Chinese Journal of Reproduction and Contraception 2021;41(9):770-775
Objective:To compare the efficiency of the early-follicular phase long-acting gonadotropin-releasing hormone agonist (GnRH-a) long protocol, the mid-luteal phase short-acting GnRH-a long protocol and the gonadotropin-releasing hormone antagonist (GnRH-A) protocol in poor ovarian responders classified by Poseidon criteria, and to explore the most appropriate and effective ovarian hyperstimulation protocol in each Poseidon criteria.Methods:The clinical data from poor ovarian responders according to the Poseidon criteria who underwent in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) in the Reproductive Medicine Center of the First Clinical College of Zhengzhou University were retrospectively analyzed by a cohort study. The patients were further divided into lower age group (<35 years) and high age group (≥35 years). The data of baseline characteristics and clinical outcomes in each ovarian hyperstimulation protocol group were analyzed and compared. Results:Totally 1249 eligible subjects were recruited in the study, including 410 patients in lower age group and 839 patients in high age group. In lower age group, early-follicular phase long-acting GnRH-a long protocol was associated with higher oocyte number (5.6±3.6 vs. 4.6±3.2 vs. 2.4±1.7, P<0.001) and No. of transferable embryos (2.2±1.6 vs. 1.6±1.6 vs. 1.1±1.1, P<0.001), lower cancellation rate of embryo transfer [20.8% (33/159) vs. 39.5% (49/124) vs. 69.3% (88/127), P<0.001], higher pregnancy rate per transfer [40.9% (65/159) vs. 29.0% (36/124) vs. 15.7% (20/127), P<0.001], and higher live birth rate [31.4% (50/159) vs. 23.4% (29/124) vs. 12.6% (16/127), P<0.001] than mid-luteal phase short-acting GnRH-a long protocol and GnRH-A protocol. However, there was no significant difference in implantation rate and abortion rate among three protocols ( P>0.05). In high age group, the early-follicular phase long-acting GnRH-a long protocol was associated with higher oocyte number (3.9±2.8 vs. 3.1±2.3 vs. 2.5±1.8, P<0.001) and No. of transferable embryos (2.8±2.0 vs. 2.4±2.0 vs. 2.1±1.7, P<0.001), lower cancellation rate of embryo transfer [19.5% (60/307) vs. 28.7% (102/355) vs. 53.3% (56/105), P<0.001] than mid-luteal phase short-acting GnRH-a long protocol and GnRH-A protocol. However, there was no statistical significance in implantation rate, pregnancy rate, abortion rate and live birth rate among the three protocols ( P>0.05). Conclusion:It seems that the early-follicular phase long-acting GnRH-a long protocol was more effective in clinical outcomes than the mid-luteal phase short-acting GnRH-a long protocol and the GnRH-A protocol for young patients with POR. It is worth emphasizing that the older the patient is, the lower the live birth rate will be. The characteristics and prognosis of patients should be used to develop clinical management strategies especially for the POR crowd.
10.Comparison of different ovarian hyperstimulation protocols efficacy in poor ovarian responders classified by Poseidon criteria
Fei LI ; Aiqin NIU ; Jianbing FENG ; Chenchen WANG ; Xingmei FENG ; Yali ZHANG ; Ying CHEN
Chinese Journal of Reproduction and Contraception 2021;41(9):770-775
Objective:To compare the efficiency of the early-follicular phase long-acting gonadotropin-releasing hormone agonist (GnRH-a) long protocol, the mid-luteal phase short-acting GnRH-a long protocol and the gonadotropin-releasing hormone antagonist (GnRH-A) protocol in poor ovarian responders classified by Poseidon criteria, and to explore the most appropriate and effective ovarian hyperstimulation protocol in each Poseidon criteria.Methods:The clinical data from poor ovarian responders according to the Poseidon criteria who underwent in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) in the Reproductive Medicine Center of the First Clinical College of Zhengzhou University were retrospectively analyzed by a cohort study. The patients were further divided into lower age group (<35 years) and high age group (≥35 years). The data of baseline characteristics and clinical outcomes in each ovarian hyperstimulation protocol group were analyzed and compared. Results:Totally 1249 eligible subjects were recruited in the study, including 410 patients in lower age group and 839 patients in high age group. In lower age group, early-follicular phase long-acting GnRH-a long protocol was associated with higher oocyte number (5.6±3.6 vs. 4.6±3.2 vs. 2.4±1.7, P<0.001) and No. of transferable embryos (2.2±1.6 vs. 1.6±1.6 vs. 1.1±1.1, P<0.001), lower cancellation rate of embryo transfer [20.8% (33/159) vs. 39.5% (49/124) vs. 69.3% (88/127), P<0.001], higher pregnancy rate per transfer [40.9% (65/159) vs. 29.0% (36/124) vs. 15.7% (20/127), P<0.001], and higher live birth rate [31.4% (50/159) vs. 23.4% (29/124) vs. 12.6% (16/127), P<0.001] than mid-luteal phase short-acting GnRH-a long protocol and GnRH-A protocol. However, there was no significant difference in implantation rate and abortion rate among three protocols ( P>0.05). In high age group, the early-follicular phase long-acting GnRH-a long protocol was associated with higher oocyte number (3.9±2.8 vs. 3.1±2.3 vs. 2.5±1.8, P<0.001) and No. of transferable embryos (2.8±2.0 vs. 2.4±2.0 vs. 2.1±1.7, P<0.001), lower cancellation rate of embryo transfer [19.5% (60/307) vs. 28.7% (102/355) vs. 53.3% (56/105), P<0.001] than mid-luteal phase short-acting GnRH-a long protocol and GnRH-A protocol. However, there was no statistical significance in implantation rate, pregnancy rate, abortion rate and live birth rate among the three protocols ( P>0.05). Conclusion:It seems that the early-follicular phase long-acting GnRH-a long protocol was more effective in clinical outcomes than the mid-luteal phase short-acting GnRH-a long protocol and the GnRH-A protocol for young patients with POR. It is worth emphasizing that the older the patient is, the lower the live birth rate will be. The characteristics and prognosis of patients should be used to develop clinical management strategies especially for the POR crowd.

Result Analysis
Print
Save
E-mail